Recruiting Breast Cancer Studies in Fairfield
ATEMPT 2.0: Adjuvant T-DM1 vs TH
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as ...
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
The purpose of this study is to generate evidence on an alternative dosing strategy for CDK4/6 inhibitors to help more patients with Metastatic Breast Cancer (MBC) (age ≥ 65 years) tolerate side effec...
About Breast Cancer Clinical Trials in Fairfield
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Fairfield, OHIO. These studies are seeking a combined 1,000 participants. Research is being sponsored by Dana-Farber Cancer Institute, American Society of Clinical Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Fairfield — FAQ
Are there breast cancer clinical trials in Fairfield?
Yes, there are 2 breast cancer clinical trials currently recruiting in Fairfield, OHIO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fairfield?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairfield research site will contact you about next steps.
Are clinical trials in Fairfield free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairfield studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Fairfield are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov